Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


145 babies given expired polio vaccines in Chinese city?and there could be more.....           Want to win over payers, pharma? Forget the 'me-too' drugs, CSL chief says.....           Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical.....           Will Trump team with Democrats to tweak the latest pricing bills? Maybe, analyst says.....           Can Amgen bone drug Evenity make a comeback? FDA, analysts aren't so sure.....           Merck's Keytruda slashes death risk by 31% in esophageal cancer victory.....           Pharma, consumer-style? New McCann Health CCO aims to inject fresh attitude.....           FiercePharmaAsia?Pfizer plant closures; Gilead-Yuhan NASH pact; Fujifilm expansions.....           First its CEO tells pharma to watch it on pricing?and then Johnson & Johnson raises them.....           Want to buy Clovis? Step up. ?Everybody knows where to find me,? CEO says.....           Teva shells out $135M to wrap Illinois AG's Medicaid pricing fraud suit.....           Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs.....           JPM recap: Must-reads of the week, from FDA to IPO to M&A and more.....           Eli Lilly plots 250 job cuts in ?100M revamp of French plant.....           As JPM 2019 wraps up, biopharma's outlook is 'cautiously optimistic,' executives say.....           Medical marketing spend is inching toward $30B, and DTC's share is growing.....           With Tesaro in the bag, GSK's cancer pipeline is pumping again, CEO says.....           With pivot to less-rare diseases, Alexion needs a new sticker-price plan, CEO says.....           Amgen's Repatha hits wall at SCOTUS but presses ahead?new price breaks included.....           Regeneron's Eylea hits double-digit growth for 2018, and it's 'far from done,' CEO says.....           Trump, frustrated over latest hikes, calls White House meeting on prices: report.....           J&J still sees plenty of opportunity in crowded immunology markets?starting with psoriasis.....           Novartis puts AI on the job to help reps say the right things to the right doctors.....           Pfizer?s tafamidis secures FDA priority review for ATTR-CM.....           Don't fret about Lilly's 3rd-to-market start in CGRP, executive says. It's got big plans in migraine and pain.....           Eli Lilly's new Trulicity TV ad counters Trump with first-ever pricing information.....           JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says.....           Teva's escaped the generics 'death spiral,' but it can't take all the credit: CEO.....           Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles.....           Don't fret about Lilly's 3rd-to-market start in CGRP, exec says. It's got big plans in migraine and pain, too.....           Charles River, Atomwise collaborate on AI-driven drug discovery.....           Ascletis and Alphamab sign licensing deal for anti-PD-L1 to treat hepatitis B and other viral diseases.....           Puma Biotechnology, Knight Therapeutics sign license deal to commercialize NERLYNX in Canada.....           Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons.....           Never mind last week's hikes. Pharma still puts pricing at the top of its worry list: report.....           Eli Lilly grabs spotlight at J.P. Morgan with $8B Loxo Oncology buyout.....           Takeda to keep consumer business, looks outside Japan for selloffs instead: CEO.....           AstraZeneca rejigs commercial ranks around cancer, biopharma in wake of Mallon's departure.....           JPM 2019: Bristol-Myers, Celgene CEOs trot out detailed case for $74B megadeal.....           Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises.....           Ironwood swipes AZ commercial hotshot Mark Mallon to fill its CEO chair.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
Latest news

Kingston University and Athlone Institute of Technology achieve APS accreditation

               

The Academy of Pharmaceutical Sciences (APS) is delighted to announce that two more institutions, Kingston University and Athlone Institute of Technology have recently achieved accreditation having gone through the accreditation process set up by the Academy towards the end of 2017.

APS is delighted that institutions see the value of our accreditation process and several others are in the process of application to us.

Achieving accreditation gives assurance to students and employers that the course meets the high standards required by the Academy and that these standards will be maintained throughout the 5-year period of accreditation.

APS believes that the accreditation process will raise the profile of pharmaceutical sciences in both academia and industry. The discipline is key in the discovery, development and manufacture of new medicines and as such is central to government initiatives to encourage the pharmaceutical industry to maintain and strengthen its strong base in the UK and Ireland.

The APS will continue to work with other stakeholders to build the science base for the ultimate benefit of patients.

To read more on the accreditation process - click here.

 
 
APS events overview

The APS is developing an exciting and informative programme of events in 2019.

Please take a look at our programme here.

OTHER EVENTS IN DEVELOPMENT
Developability for Biologicals
Inhaled Workshop
Basic Biopharmaceutics workshop 

Follow us
 
Upcoming Events
APS Additive Manufacturing Symposium
27 March 2019
APS Developability Workshop
17 - 18 April 2019
APS Industrial Insights 2019
25 - 26 April 2019
10th APS International PharmSci conference 2019
11 - 13 September 2019
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351, Fax: 0116 274 7365, Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.

Privacy Policy:
For details on the data we collect and how we store and process your data please refer to our Privacy Policy.